NATIONAL TRANSPORTATION SAFETY BOARD SAFETY RECOMMENDATION, I-00-5

This safety recommendation, addressed to the Honorable Jane E. Henney, M.D., Commissioner, U.S. Food and Drug Administration (FDA), recommends that the FDA: Establish a clear, consistent, easily recognizable warning label for all prescription and over-the-counter medications that may interfere with an individual's ability to operate a vehicle; and require that the label be prominently displayed on all packaging of such medications (I-00-5).

Language

  • English

Media Info

  • Features: Appendices;
  • Pagination: 26 p.

Subject/Index Terms

Filing Info

  • Accession Number: 00796977
  • Record Type: Publication
  • Source Agency: National Highway Traffic Safety Administration
  • Report/Paper Numbers: HS-042 981
  • Files: HSL, USDOT
  • Created Date: Aug 21 2000 12:00AM